✦ LIBER ✦

Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome

✍ Scribed by Caterina Pandolfi; Antonella Zugaro; Francesca Lattanzio; Stefano Necozione; Arcangelo Barbonetti; Maria Simonetta Colangeli; Sandro Francavilla; Felice Francavilla

Book ID: 119325883
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 141 KB
Volume: 57
Category: Article
ISSN: 1532-8600
DOI: 10.1016/j.metabol.2008.02.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The insulin resistant subphenotype of po

The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis

✍ Eliran Mor; Arus Zograbyan; Peyman Saadat; Aykut Bayrak; David E Tourgeman; Chun 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Clinical, ultrasound and biochemical fea

Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis

✍ Hickey, M.; Doherty, D. A.; Atkinson, H.; Sloboda, D. M.; Franks, S.; Norman, R. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 277 KB

Insulin resistance and its relationship

Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome

✍ Cankaya, Sevil; Demir, Berfu; Aksakal, Sezin Erturk; Dilbaz, Berna; Demirtas, Ca 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Effect of sibutramine on weight reductio

Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome

✍ Neoklis A. Georgopoulos; Ilias Katsikis; Dimos Florakis; Dimitrios Panidis; Evan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Prevalence of androgenic alopecia in pat

Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features

✍ Quinn, Molly; Shinkai, Kanade; Pasch, Lauri; Kuzmich, Lili; Cedars, Marcelle; Hu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Spironolactone in the treatment of polyc

Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile

✍ Zulian, E.; Sartorato, P.; Benedini, S.; Baro, G.; Armanini, D.; Mantero, F.; Sc 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 77 KB